It's our birthday

Article

Welcome to the October issue of OTE and the second anniversary edition of our magazine. Two years ago this month saw the first issue of OTE hit desks across Europe.

On that note, I was pleased to meet with some of you during the recent ESCRS congress in Stockholm. Thank you so much to those of you who took the time to stop by and visit us and to tell us what you think of our magazine. It really did mean a lot to me. My only regret is that I did not have enough time to spend with you during the event because I was working with our team of writers to cover daily news from the congress. In this issue we show you just some of the highlights from the annual meeting, however, OTE's full coverage of the ESCRS congress can be accessed by visiting http://www.oteurope.com/.

Thank you once again for your very kind support of OTE over the past two years. It has been my pleasure to work with you and I look forward to continued successes.

Fedra Pavlou
Editor
fpavlou@advanstar.com

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.